NCT06824155
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06824155
Title HEAT Trial (HER2 Antibody Therapy with Lutetium-177) (RAD202)
Acronym RAD202
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Radiopharm Theranostics, Ltd
Indications
Therapies
Age Groups: adult | senior
Covered Countries AUS


No variant requirements are available.